Innovation

As William Shatner prepares to be beamed up at age 90 for his first real-life spaceflight, he’s bringing out the awe in people around a rural Texas spaceport.

Now in its third year, the B. PHL Innovation Festival kicks off Wednesday and runs through Friday, Oct. 1.

The news comes as the enrollment for students majoring in science, technology, engineering and mathematics (STEM) has been growing at the nation’s first HBCU.

Bikes, scooters, pedestrians - oh my! How will Philadelphia make routes safer (and maybe greener) for all travelers to share?

The goal is to give the teens, several of whom have criminal records, the knowledge and skills to go into business for themselves or join the city’s building trades unions.

The entrepreneur began to build her yarn empire at 15. But the idea for a vending machine came to Outterbridge during the coronavirus pandemic.

Newark Free Library offers its “Library of Things” collection, so residents can borrow things like ukuleles, record players, and even a cornhole set.

The Wilmington-based ReManned Project hopes to connect 10,000 Black men with mentors to help process trauma and find success in their work and personal lives.

The Philly District Attorney’s office has begun diverting young people into an after-school arts program for a chance to expunge their records.

Of the students who made it through four years at Parkway Middle College, 95% are graduating with both a high school diploma and an associate’s degree.

Artists, once hesitant to bring strangers into their studios, now agree to do POST via digital tools.

About 40,000 babies are born with heart defects annually. The FDA approved a procedure less invasive than the surgery many get during their lives.

Doctors hope the one-time treatment, which involves permanently altering DNA in blood cells with a tool called CRISPR, may treat and possibly cure sickle cell disease.

PBS Newshour's John Yang reflects on his experience participating in Moderna's vaccine trial. "It started off with self-interest — I wanted to get the vaccine sooner."

The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 in a study.